The screening question isn't "will they pay?" It's "do they have someone who can make this project move?" Those two questions almost never have the same answer.
The industrial AR company had everything we look for on paper.
Series A funded. Real manufacturing customers. A CTO who'd worked at Bosch and knew the technical problem better than we did. A VP of Operations who'd championed the deal internally and got it signed in three weeks.
Three weeks was a record for us. We took it as a positive signal.
It wasn't. It meant the VP hadn't talked to anyone else yet.
By Week 4, we'd been introduced to: IT security (hadn't heard of us), the data governance team (needed their own vendor assessment), and three plant floor managers whose cooperation we'd need to access the sensor logs the entire project depended on. None of them were hostile. None of them had our project anywhere in their priorities.
The VP who signed had authority at the top. He had almost no leverage with the people whose cooperation we needed in the middle. We spent four months navigating an organization that had technically approved us but hadn't actually bought in.
The project delivered. Barely. The internal story the client told afterward was: AI is complicated.
That was our third deployment. After six, we've developed a specific fear of fast-moving sponsors.
Not because fast-moving sponsors are bad people. Because fast-moving sponsors are, by definition, people who haven't pre-negotiated the organization before signing you. They're selling you into a company that hasn't said yes yet. Your contract is the beginning of the sales process, not the end of it.
The deals that have gone cleanest — the auto retail group, the fertility coordination network, the real estate staging company — all took longer to close. Not because the buyers were slower. Because they were doing work before we arrived: mapping dependencies, running internal conversations, identifying who would need to be involved.
A slow close often means an organized client. A fast close often means an enthusiastic individual with a corporate credit card and an org chart they haven't looked at in a while.
THE VARIABLE NOBODY SCREENS FOR
We've gotten better at asking one question in early conversations that tells us more than any other:
"Who in your organization knows both the business process we'd be changing and where the underlying data lives?"
This sounds like a technical question. It isn't. It's an organizational one.
Every B2B AI project we've worked on eventually required someone who could translate between two worlds: the operational logic of the business (why does this workflow work the way it does, what breaks if we change it, what do the edge cases mean) and the data reality (where does this actually live, who owns it, what's missing, what's dirty).
In successful deployments, that person exists. Usually it's a senior ops manager or an analyst who's been at the company long enough to know both sides. They're not always in the room when you're selling. But when you ask about them, the sponsor knows immediately who they are.
In failing deployments, that person either doesn't exist, or exists but isn't available. The business knowledge lives in one team. The data access lives in another. Getting them to communicate with each other, on your timeline, for a project that isn't their top priority, is not a delivery problem. It's a structural condition you can't engineer around.
You can hire better engineers. You can't hire someone else's organizational memory.
The fertility coordination company: the question that changed the scoping call.
We were fifteen minutes into a discovery call with a VP of Clinical Operations at a nine-location fertility network. She was technically literate, genuinely excited, had real budget.
We asked: "Who on your team knows both how your coordinators actually handle insurance verification, and where that data lives in your systems?"
She paused. Then she said: "That's probably Maya. She's been here seven years and she runs our Athena implementation."
We asked if Maya could join the next call.
She did. And the scoping conversation that followed was a completely different kind of conversation — not "here's what AI can do" but "here's specifically what breaks in your process and here's exactly where in your data architecture we'd need to touch."
That deployment finished three weeks early. Maya was available, empowered, and genuinely invested in the outcome. When we hit data quality issues, she already knew they existed — she just hadn't had a reason to fix them before.
The project worked because we didn't have to discover the organization. We had a guide.
The medical device company where the guide didn't exist.
A different engagement, different industry. The sponsor was a VP of Clinical Operations — similar profile, similar budget.
We asked the same question about who knew both the business process and the data.
He named someone in IT. We asked if that person understood the clinical workflow side.
"He understands the systems," the VP said. "The workflow stuff is kind of distributed across the team."
That answer, which sounded reasonable, was a description of a structural problem. The IT person knew the systems but not the clinical logic. The clinical team knew the workflows but didn't have data access. The VP understood the problem at the executive level but didn't have enough technical depth to bridge the two.
We spent the first six weeks of that project doing work that Maya would have done in three days: mapping the actual workflow against the data schema, identifying which fields meant what to which team, finding the seventeen places where the same patient ID appeared in four different formats across three different systems.
The project was never at risk of failure. It was at risk of consuming twice the timeline — which it did — and producing a client whose internal story was "this took longer than expected."
WHAT THIS MEANS FOR HOW YOU SCREEN
The conventional wisdom in B2B AI sales is to qualify on budget, authority, need, and timeline. That framework predates AI deployment. It was designed for software sales, where the product can be configured in days and the risk is commercial, not operational.
AI deployment risk isn't commercial. It's organizational. The question isn't whether they can pay. The question is whether they can move.
First, find the connector before you sign. The connector — the person who bridges business logic and data reality — is the most important person in your project who isn't on your team. You want to know they exist, that they're available, and that the sponsor has the organizational standing to pull them into your work. If you can't identify this person in the sales process, you'll spend your first month finding them — and in some cases, you'll discover they don't exist.
Second, read the speed of the close. A fast-moving sponsor is exciting. It is also a specific kind of risk: someone who is selling you inward, into an organization that hasn't said yes yet. Slow down fast closes by asking for introductions to the people you'll need post-signing. If the sponsor can't make those introductions before you sign — or is reluctant to — you now understand the shape of the organization you're walking into.
Third, ask who failed last time. Most enterprise organizations that are buying AI have already tried something that didn't fully work — a vendor who underdelivered, an internal initiative that stalled, a pilot that never moved to production. Ask about it. The story they tell you is diagnostic. If the failure was "we ran out of time to do the data work" or "the vendor needed things from IT and it took forever" — you've just heard a description of the organizational conditions that are almost certainly still present. Those conditions don't go away because you showed up.
THE PATTERN WE KEEP SEEING
Across six deployments, the cleanest predictor of project success wasn't the quality of our proposal, or the technical complexity of the problem, or even the budget available.
It was whether the organization had a functioning internal bridge between business operations and technical infrastructure — and whether that bridge was available to us.
When that person exists and is empowered, AI deployments are mostly engineering problems. You do the work, you ship the thing, the client is happy.
When that bridge doesn't exist, AI deployments are organizational change projects that happen to involve some engineering. Those projects are harder, slower, and more expensive for everyone involved — and they almost always produce a client who walks away saying "AI didn't work the way we expected," when what they mean is "our organization wasn't set up for this."
The second story is the one that travels. It's the story that makes the next AI founder's sales cycle harder.
Choosing your first client badly doesn't just cost you a project. It contributes to the ambient skepticism in the market that every AI company is fighting.
ONE THING WE MIGHT BE WRONG ABOUT
Everything above assumes you have the pipeline to be selective. If you need this deal to make payroll, the calculus is different — we've been there, and we're not going to tell you that principled rejection is easy when rent is due.
What we'd say instead: if you take the deal knowing the organizational conditions are bad, change what you do with it. Don't try to convert it into a reference client. Don't use it as a case study. Treat it as paid organizational consulting, document what you learn, and figure out how to surface the connector question earlier in your next sales process.
We might also be wrong about whether the "connector" model generalizes across industries. In regulated industries — medical, financial, pharmaceutical — data governance is often so complex that no single person bridges the operational and technical sides. There may be a multi-person version of this framework we haven't fully mapped yet. If you've deployed in those environments and have a different read, we'd actually like to hear it.
Working notes from B2B AI deployment in North America. Part of an ongoing series on what we keep noticing across wildly different industries — and what the industry isn't ready to say out loud.